PXD018673-2

PXD018673 is an original dataset announced via ProteomeXchange.

Title	N-glycomic profiling of colorectal cancer according to tumor stage and location
Description	Alterations in glycosylation are seen in many types of cancer, including colorectal cancer (CRC). CRC is known to display glycosylation alterations. Glycans, the sugar moieties of glycoconjugates, are involved in many important functions relevant to cancer, such as cell signaling and adhesion, and may can be of value as biomarkers. In this study, we have used mass spectrometry to analyze the N-glycan profiles of 35 CRC tissue samples from patients with tumors in the right or left colon and 10 healthy tissue samples from non-CRC patients who underwent operations for other reasons. The tumor samples were divided into groups depending on tumor location (right or left colon) and stage (II or III), while the healthy samples were divided into right or left side of the colon. The levels of neutral and acidic N-glycan compositions and glycan classes were analyzed in a total of ten different groups. Surprisingly, there were no significant differences in glycan levels when all right- and left-sided CRC samples were compared, and few differences (such as in the abundance of the neutral N-glycan H3N5) were seen when the samples were divided according to both location and stage. Multiple significant differences were found in the levels of glycans and glycan classes when stage II and III samples were compared, and these glycans could be of value as candidates for new markers of cancer progression. In order to validate our findings, we analyzed healthy tissue samples from the right and left colon and found no significant differences in the levels of any of the glycans analyzed, confirming that our findings when comparing CRC samples from the right and left colon are not due to normal variations in the levels of glycans between the healthy right and left colon. Additionally, the levels of the acidic glycans H4N3F1P1, H5N4F1P1, and S1H5N4F1 were found to change in a cancer-specific but colon location-nonspecific manner, indicating that CRC affects glycan levels in similar ways, regardless of tumor location.
HostingRepository	PRIDE
AnnounceDate	2020-06-10
AnnouncementXML	Submission_2020-07-05_22:22:33.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Tero Satomaa
SpeciesList	scientific name: Homo sapiens (Human); NCBI TaxID: 9606;
ModificationList	monosodium salt
Instrument	ultraflex

Revision	Datetime	Status	ChangeLog Entry
0	2020-04-20 06:25:17	ID requested
1	2020-06-09 23:22:57	announced
⏵ 2	2020-07-05 22:22:34	announced	2020-07-06: Updated publication reference for PubMed record(s): 32598367.

Holm M, Nummela P, Heiskanen A, Satomaa T, Kaprio T, Mustonen H, Ristim, ä, ki A, Haglund C, N-glycomic profiling of colorectal cancer according to tumor stage and location. PLoS One, 15(6):e0234989(2020) [pubmed]

submitter keyword: N-glycan cancer MALDI-TOF mass spectrometry

Tero Satomaa
contact affiliation	Glykos Finland Ltd., Helsinki, Finland
contact email	tero.satomaa@glykos.fi
lab head
Tero Satomaa
contact affiliation	Glykos Finland Ltd.
contact email	tero.satomaa@glykos.fi
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/06/PXD018673

PRIDE project URI

• PRIDE
  1. PXD018673
     1. Label: PRIDE project
     2. Name: N-glycomic profiling of colorectal cancer according to tumor stage and location